Clampdown on Cough Syrup Quality: Ministry Sets Strict Compliance Rules
The Union Health Ministry emphasizes the need for drug manufacturers to adhere to Revised Schedule M in the wake of child deaths linked to contaminated cough syrups. A high-level meeting with state officials reviewed drug quality compliance, focusing on rational use among children and regulatory actions against violators.

- Country:
- India
The Union Health Ministry has stressed the enforcement of Revised Schedule M compliance among drug manufacturers, following concerns about the contamination of cough syrups linked to child deaths.
Led by Union Health Secretary Punya Salila Srivastava, a high-level meeting reviewed drug quality norms and urged rational use of cough syrups, especially in children, to prevent unnecessary pharmacological treatment.
Investigations revealed Nine out of ten tested samples met quality standards, with regulatory action initiated against one violative sample. The central team's inspection and ongoing awareness efforts highlight the serious stance on drug manufacturing regulation.
(With inputs from agencies.)
ALSO READ
Tragedy Unveiled: Toxic Cough Syrup Linked to Child Deaths
Madhya Pradesh Bans Coldrif Cough Syrup Amid Child Deaths Crisis
Concerns Arise Over Cough Syrup Amid Child Deaths in Rajasthan
Telangana issues 'public alert' on Coldrif syrup after child deaths in MP, Rajasthan
Crackdown on Contaminated Cough Syrups in Uttarakhand Amid Child Deaths